Literature DB >> 28751012

The J to T-peak interval as a biomarker in drug safety studies: A method of accuracy assessment applied to two algorithms.

W Brian Chiu1, Johan de Bie2, David W Mortara3.   

Abstract

OBJECTIVES: To evaluate performance of J-to-T-peak (JTP) measurements of 12-lead ECGs, in a five-arm study using drugs with various levels of electrolyte channel block.
METHODS: The novel evaluation method distinguishes between different aspects of measurement. "Random noise" is the variability among repeated measurements made without changing the conditions. "Context noise" is the variability of changes in context of the measurement, e.g. T-wave morphology, autonomic nervous system state.
RESULTS: The average random noise of our RR-corrected JTPc measurements in standard deviations was 3.0 ms and not dependent on the drug. The average context noise was 4.0 ms for ranolazine, verapamil, and placebo, and 8.8 ms for dofetilide and quinidine. Measurement consistency is corroborated by linear fit confidence intervals of baseline- and placebo-corrected JTPc versus drug concentration.
CONCLUSIONS: Systematic differences were found in JTPc drug response between the Mortara method and published data. Residual signal component in the context noise may influence future study design.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  J-Tpeak interval; Performance evaluation; RR-correction

Mesh:

Substances:

Year:  2017        PMID: 28751012     DOI: 10.1016/j.jelectrocard.2017.07.011

Source DB:  PubMed          Journal:  J Electrocardiol        ISSN: 0022-0736            Impact factor:   1.438


  2 in total

1.  An evaluation of multiple algorithms for the measurement of the heart rate corrected JTpeak interval.

Authors:  Jean-Philippe Couderc; Shiyang Ma; Alex Page; Connor Besaw; Jean Xia; W Brian Chiu; Johan de Bie; Jose Vicente; Martino Vaglio; Fabio Badilini; Saeed Babaeizadeh; Cheng-Hao Simon Chien; Mathias Baumert
Journal:  J Electrocardiol       Date:  2017-09-01       Impact factor: 1.438

Review 2.  Mechanistic Model-Informed Proarrhythmic Risk Assessment of Drugs: Review of the "CiPA" Initiative and Design of a Prospective Clinical Validation Study.

Authors:  Jose Vicente; Robbert Zusterzeel; Lars Johannesen; Jay Mason; Philip Sager; Vikram Patel; Murali K Matta; Zhihua Li; Jiang Liu; Christine Garnett; Norman Stockbridge; Issam Zineh; David G Strauss
Journal:  Clin Pharmacol Ther       Date:  2017-11-16       Impact factor: 6.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.